Isracann Biosciences Inc. (ISCNF) Research

Isracann Biosciences Inc., operating with its subsidiary companies, focuses on the growth and supply of medical-grade cannabis throughout Israel. The firm also dedicates resources to establishing new cultivation infrastructure. Additionally, it ships its products internationally to Germany. The company rebranded to Isracann Biosciences Inc. in October 2019, having previously been known as Atlas Blockchain Group Inc. Founded in 2010, its corporate headquarters are situated in Vancouver, Canada.

Market snapshot

Symbol
ISCNF
Price
$0.00
Day change
0.00%
Market cap
$2.6M
P/E ratio
-0.47x
52-week range
0.00001-0.0001
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic

Peer companies

  • Avicanna Inc. (AVCNF)
  • INDVR Brands Inc. (CAAOF)
  • Choom Holdings Inc. (CHOOF)
  • Charlotte's Web Holdings, Inc. (CWBHF)
  • Molecule Holdings Inc. (EVRRF)
  • Global Pharmatech, Inc. (GBLP)
  • MediPharm Labs Corp. (MEDIF)
  • Institute of Biomedical Research Corp. (MRES)

Open Isracann Biosciences Inc. (ISCNF) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.